SCHEMBL25913327

SCHEMBL25913327

CNc1ccc2c(c1)Nc1ccccc1S2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 13/20 0.59
GAA P10253 7/20 0.59
MAPT P10636 7/20 0.59
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
ALOX15 P16050 3/20 0.59
TDP1 Q9NUW8 3/20 0.59
BCHE P06276 2/20 0.59
ACHE P22303 2/20 0.59
SNCA P37840 2/20 0.59
POLB P06746 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
ADORA3 P0DMS8 1/20 0.59
ALOX12 P18054 1/20 0.59
MAOA P21397 1/20 0.59
CNR1 P21554 1/20 0.59
PTGS1 P23219 1/20 0.59
SLC6A2 P23975 1/20 0.59
HTR2C P28335 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20488743 0.90 NOX1 (0.59) NOX1GAAMAPTMEN1KMT2A
SCHEMBL1925368 0.80 SNCA (0.50) NOX1GAAMAPTMEN1KMT2A
SCHEMBL28996737 0.79 NOX1 (0.53) NOX1GAAMAPTMEN1KMT2A
SCHEMBL27484766 0.77 SNCA (0.44) NOX1GAAMAPTMEN1KMT2A
Phenothiazine SCHEMBL29352248 0.77 NOX1 (1.00) NOX1GAAMAPTMEN1KMT2A
Phenothiazine SCHEMBL29349533 0.77 NOX1 (1.00) NOX1GAAMAPTMEN1KMT2A
Phenothiazine SCHEMBL6315328 0.77 NOX1 (1.00) NOX1GAAMAPTMEN1KMT2A
Phenothiazine SCHEMBL9114 0.77 NOX1 (1.00) NOX1GAAMAPTMEN1KMT2A
Phenothiazine SCHEMBL2504207 0.77 NOX1 (1.00) NOX1GAAMAPTMEN1KMT2A
SCHEMBL225829 0.77 NOX1 (0.65) NOX1GAAMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230226226-A1 MULTI-SIGNAL FLUORESCENT PROBE FOR EARLY DIAGNOSIS OF TUMORS, AND PREPARATION AND USE THEREOF HUNAN CANCER HOSPITAL (CN) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230226226-A1 MULTI-SIGNAL FLUORESCENT PROBE FOR EARLY DIAGNOSIS OF TUMORS, AND PREPARATION AND USE THEREOF KCNN2, IWS1, KCNN1 NOX1 3114/4885GAA 2588/4885MAPT 2402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.